Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outcomes in Pharmacotherapy of Social Phobia
NCT00282828Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2006
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of clonazepam, venlafaxine in Social Anxiety Disorder (SAD), sponsored by Massachusetts General Hospital. Started Mar 2006; status: completed.
02
Drugs
clonazepamvenlafaxine
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT00282828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00282828.